Previous 10 | Next 10 |
New super-charged serum helps men and women minimize the size of enlarged facial pores NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the newest addition to the DERMAdoctor ® Picture Porefect ® collection: 15% Niacinamide ...
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present a company overview at the LD Micro Main Event XV ...
A California-based %Biotech company turned heads Tuesday in early trading after the company announced that it secured ‘significant’ orders for their %DERMAdoctor ® Kakadu ® C 20% Vitamin C Serum with Ferulic Acid & Vitamin E. This news made traders ea...
NovaBay Pharmaceuticals ( NYSE: NBY ) on Tuesday said it received significant orders for DERMAdoctor Kakadu C anti-aging serum ahead of the holiday season. "These orders will favorably impact DERMAdoctor’s revenue contribution for the 2022 third and fourth ...
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces significant orders for DERMAdoctor ® Kakadu ® C 20% Vitamin C Serum with Ferulic Acid & Vitamin E. “We are excited to share that one of our best-selling products, DERMAdocto...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock We’re starting off the trading week with a look at the biggest pre-market stock movers for Monday morning! Moving stocks this morning are a delisting notice, a corporate update, and more....
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that select Avenova brand products and all DERMAdoctor brand products will...
NovaBay Pharmaceuticals ( NYSE: NBY ) said it had received a notice from the NYSE that its stock had been selling for a low price per share for a substantial period of time. Under the NYSE guide, the company could either do a reverse stock split of its stock...
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that on October 3, 2022 it received a notice from the NYSE American LLC that the Company’s common stock has been selling for a low price per share for a substantial period of time. As a result, pursu...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Ladenburg Thalmann 2022 Healthcare Conf...
News, Short Squeeze, Breakout and More Instantly...
NovaBay Pharmaceuticals Inc. Company Name:
NBY Stock Symbol:
NYSE Market:
NovaBay Pharmaceuticals Inc. Website:
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Ea...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova ® -branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales were 17% higher compared with Prime Day 2023 and were up 40% over ...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants f...